Jove
Visualize
Contact Us

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Frameless trigeminal neuralgia radiosurgery with a dedicated linear accelerator: From equipment commissioning to initial clinical results].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Tracing probiotic producing bacterial species from gut of buffalo (Bubalus bubalis), South-East-Asia.

Brazilian journal of biology = Revista brasleira de biologia·2022
Same author

Follow-up after emergency laparotomy suggests high one- and five-year mortality with risk stratified by ASA.

Annals of the Royal College of Surgeons of England·2021
Same author

Neural correlates of consciousness and related disorders: From phenotypic descriptors of behavioral and relative consciousness to cortico-subcortical circuitry.

Neuro-Chirurgie·2021
Same author

Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021
Same author

Hypofractionated stereotactic radiotherapy for large brain metastases: Optimizing the dosimetric parameters.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 15, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

[Therapeutic indications for central nervous system cavernomas].

J Chazal1, T Khalil, L Sakka

  • 1Service de neurochirurgie A, hôpital Gabriel-Montpied, CHU de Clermont-Ferrand, BP 69, 63003 Clermont-Ferrand cedex 01, France. jchazal@chu-clermontferrand.fr

Neuro-Chirurgie
|May 15, 2007
PubMed
Summary

Therapeutic decisions for central nervous system cavernomas depend on lesion characteristics and presentation. Surgery is often indicated for symptomatic or high-risk lesions, especially those causing drug-resistant epilepsy.

More Related Videos

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

Related Experiment Videos

Last Updated: Jul 15, 2026

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
11:51

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models

Published on: August 16, 2010

Area of Science:

  • Neurology
  • Neurosurgery
  • Vascular Neurology

Context:

  • Central nervous system (CNS) cavernomas are vascular malformations requiring careful therapeutic consideration.
  • Indications for intervention are based on lesion characteristics, location, and clinical presentation.
  • Management strategies range from observation to surgical resection or radiosurgery.

Purpose:

  • To outline the therapeutic indications for CNS cavernomas.
  • To provide a framework for decision-making in managing these lesions.
  • To review current evidence regarding surgical and non-surgical treatment options.

Summary:

  • Therapeutic indications for CNS cavernomas are determined by lesion multiplicity, location (exophytic vs. deep), and symptomatic presentation.
  • Symptomatic cavernomas generally warrant surgery, particularly those causing drug-resistant epilepsy, unless located in critical deep functional zones.
  • Prevention of hemorrhage is a key consideration, favoring surgery for lesions in non-functional areas or those with a high bleeding risk, especially in the brain stem.

Impact:

  • This guidance aids clinicians in optimizing treatment strategies for CNS cavernomas.
  • Improved understanding of indications may lead to better patient outcomes and reduced morbidity.
  • Highlights the need for further research, particularly randomized controlled trials, to refine treatment protocols.